Cargando…
Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease
BACKGROUND: Chronic kidney disease (CKD) is a global public health problem. Currently, as for advanced CKD populations, medication options limited in angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB), which were partially effective. A Chinese herbal compound, Bu...
Autores principales: | Mao, Wei, Zhang, Lei, Zou, Chuan, Li, Chuang, Wu, Yifan, Su, Guobin, Guo, Xinfeng, Wu, Yuchi, Lu, Fuhua, Lin, Qizhan, Wang, Lixin, Bao, Kun, Xu, Peng, Zhao, Daixin, Peng, Yu, Liang, Hui, Lu, Zhaoyu, Gao, Yanxiang, Jie, Xina, Zhang, La, Wen, Zehuai, Liu, Xusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562196/ https://www.ncbi.nlm.nih.gov/pubmed/26351087 http://dx.doi.org/10.1186/s12906-015-0830-1 |
Ejemplares similares
-
Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
por: Mao, Wei, et al.
Publicado: (2021) -
Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation
por: Zhang, Difei, et al.
Publicado: (2021) -
Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway
por: Mo, Yenan, et al.
Publicado: (2021) -
Auricular acupressure for insomnia in hemodialysis patients: study protocol for a randomized controlled trial
por: Wu, Yuchi, et al.
Publicado: (2018) -
Auricular Acupressure on Specific Points for Hemodialysis Patients with Insomnia: A Pilot Randomized Controlled Trial
por: Zou, Chuan, et al.
Publicado: (2015)